NewsRoom Articles - Page 1279 of 1389

MondayMar 13, 2017 8:00 pm

Hydrogenics Corp. (NASDAQ: HYGS) Starts Presentation at 29th Annual ROTH Conference

Hydrogenics (NASDAQ: HYGS) is engaged in engineering and building the technologies required to enable the acceleration of a global power shift. Headquartered in Mississauga, Ontario, the company provides hydrogen generation, energy storage and hydrogen power modules to its customers and partners around the world. Hydrogenics has manufacturing sites in Germany, Belgium and Canada and service centers in Russia, China, India, Europe, the US and Canada. For more information, visit the company’s website at www.hydrogenics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

MondayMar 13, 2017 8:00 pm

Remark Media, Inc. (NASDAQ: MARK) Starts Presentation at 29th Annual Roth Conference

Remark Media (NASDAQ: MARK) operates and acquires digital media properties across multiple verticals that deliver content worldwide. The company leverages its digital media assets to target the Millennial demographic which provides it with access to markets. It operates KanKan, a social media application and data intelligence platform, which aggregates content and consumer-shopping data across social media platforms. The company’s Vegas.com offers users the ability to book lodging, air travel, show tickets and tours. Its Roomlia mobile hotel-booking application allows users to reserve lodging at participating hotels. For more information, visit the company’s website at www.remarkmedia.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

MondayMar 13, 2017 8:00 pm

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) Starts Presentation at 29th Annual ROTH Conference

CymaBay Therapeutics (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist. CymaBay has recently completed a phase 2 study of seladelpar in patients with primary biliary cholangitis as well as a pilot phase 2 study in patients with homozygous familial hypercholesterolemia, establishing proof-of-concept in both indications. For more information, visit the company’s website at www.cymabay.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news…

MondayMar 13, 2017 7:30 pm

Ballard Power Systems, Inc. (NASDAQ: BLDP) Starts Presentation at 29th Annual ROTH Conference

Ballard Power Systems (NASDAQ: BLDP) is engaged in the development and commercialization of proton exchange membrane fuel cells worldwide. The company is primarily involved in the design, development, manufacture, sale and service of fuel cell stacks, modules and systems for various applications. Ballard also develops methanol clean energy backup power systems, as well as provides engineering services for various fuel cell applications including portable power, material handling, and telecom backup power, as well as power product markets of bus and tram applications. For more information, visit the company’s website at www.ballard.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

MondayMar 13, 2017 7:30 pm

ARI Network Services, Inc. (NASDAQ: ARIS) Starts Presentation at 29th Annual ROTH Conference

ARI Network Services (NASDAQ: ARIS) (“ARI”) offers a suite of SaaS, software tools, and marketing services to help dealers, equipment manufacturers and distributors in selected vertical markets Sell More Stuff!™ -- online and in-store. The company’s innovative products are powered by a proprietary data repository of enriched original equipment and aftermarket electronic content spanning more than 17 million active part and accessory SKUs and 750,000 equipment models. ARI removes the complexity of selling and servicing new and used vehicle inventory, parts, garments and accessories for customers in the automotive tire and wheel aftermarket, power-sports, outdoor power equipment, marine, home medical…

MondayMar 13, 2017 7:30 pm

Castle Brands, Inc. (NYSE: ROX) Starts Presentation at 29th Annual ROTH Conference

Castle Brands (NYSE: ROX) develops, markets, imports, and sells beverage alcohol products in the United States and internationally. Its product categories include rum, whiskey, liqueurs, vodka, tequila, wine, and other spirits, as well as ginger beer and ready-to-drink cocktails. The company offers its products under the Jefferson's®, Goslings® Rums, Knappogue Castle Whiskey®, Clontarf® Irish Whiskey, Pallini® Limoncello, Boru® Vodka, Brady's® Irish Cream, The Arran Malt® Single Malt Scotch Whisky, The Robert Burns Scotch Whisky and Machrie Moor Scotch Whisky brands through a network of wholesale distributors and state-operated agencies. Castle Brands was incorporated in 2009 and is based in New York, New York. For more information,…

MondayMar 13, 2017 7:30 pm

Agile Therapeutics, Inc. (NASDAQ: AGRX) Starts Presentation at 29th Annual ROTH Conference

Agile Therapeutics (NASDAQ: AGRX) is a specialty pharmaceutical company that focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate, Twirla, is a once-weekly contraceptive patch currently in phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. For more information, visit…

MondayMar 13, 2017 7:30 pm

Connection, Inc. (NASDAQ: CNXN) Starts Presentation at 29th Annual ROTH Conference

Connection (NASDAQ: CNXN), is the combined corporate brand name for PC Connection, Inc. along with its subsidiaries PC Connection Sales, GovConnection, and MoreDirect. Headquartered in Merrimack, NH with offices throughout the United States, the company continues to deliver custom-configured computer systems overnight from its certified technical configuration lab at its distribution center in Wilmington, OH. In addition, the company has over 2,500 technical certifications that permits it to solve the most complex issue. Connections also services international customers through its GlobalServe subsidiary, a global IT procurement and service management company. For more information, visit the company’s website www.connection.com. About NetworkNewsWire…

MondayMar 13, 2017 7:30 pm

Charles & Colvard Ltd. (NASDAQ: CTHR) Starts Presentation at 29th Annual ROTH Conference

Charles & Colvard (NASDAQ: CTHR) is the original creator of Forever Classic™, Forever Brilliant® and Forever One™ moissanite gemstones for fine jewelry. Moissanite is unique, available in three color grades (colorless, near-colorless and faint color) and produced from silicon carbide (SiC) crystals. Charles & Colvard Created Moissanite® is sold with a Certificate of Authenticity and Limited Lifetime Warranty to wholesale distributors, manufacturers, retailers, TV shopping networks and designers as loose stones or set in a wide variety of quality metal setting options. Charles & Colvard, Ltd. also sells direct to consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, and…

MondayMar 13, 2017 7:30 pm

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) Starts Presentation at 29th Annual Roth Conference

Syndax Pharmaceuticals (NASDAQ: SNDX) is a late-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics in oncology. The company’s lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. For more information, visit the company’s website at www.syndax.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Hydrogenics Corp. (NASDAQ: HYGS) Starts Presentation at 29th Annual ROTH Conference

Remark Media, Inc. (NASDAQ: MARK) Starts Presentation at 29th Annual Roth Conference

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) Starts Presentation at 29th Annual ROTH Conference

Ballard Power Systems, Inc. (NASDAQ: BLDP) Starts Presentation at 29th Annual ROTH Conference

ARI Network Services, Inc. (NASDAQ: ARIS) Starts Presentation at 29th Annual ROTH Conference

Castle Brands, Inc. (NYSE: ROX) Starts Presentation at 29th Annual ROTH Conference

Agile Therapeutics, Inc. (NASDAQ: AGRX) Starts Presentation at 29th Annual ROTH Conference

Connection, Inc. (NASDAQ: CNXN) Starts Presentation at 29th Annual ROTH Conference

Charles & Colvard Ltd. (NASDAQ: CTHR) Starts Presentation at 29th Annual ROTH Conference

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) Starts Presentation at 29th Annual Roth Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search